Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects-Reference-Cited by-同舟云学术

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Published:2008-06-25 Issue:6 Volume:84 Page:679-683
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Krishna R,Bergman AJ,Jin B,Fallon M,Cote J,Van Hoydonck P,Laethem T,Gendrano III IN,Van Dyck K,Hilliard D,Laterza O,Snyder K,Chavez-Eng C,Lutz R,Chen J,Bloomfield DM,De Smet M,Van Bortel LM,Gutierrez M,Al-Huniti N,Dykstra K,Gottesdiener KM,Wagner JA

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Plasma cholesteryl ester transfer protein

2. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility

3. Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein

4. Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans

5. Pfizer stops clinical trials of heart drug

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments;Current Atherosclerosis Reports;2023-12-22

2. Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial;Nature Medicine;2022-08

3. Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class Properties;Journal of Medicinal Chemistry;2021-08-10

4. Pharmacokinetics, Safety and Tolerability of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein (CETP) Inhibitor, After Single and Multiple Doses in Healthy Chinese Subjects;Advances in Therapy;2021-06-08

5. A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519;Pharmaceutics;2020-06-19